Bladder Cancer Immunotherapy by BCG Is Associated with a Significantly Reduced Risk of Alzheimer’s Disease and Parkinson’s Disease

Bladder Cancer Immunotherapy by BCG Is Associated with a Significantly Reduced Risk of Alzheimer’s Disease and Parkinson’s Disease

Bacillus Calmette–Guerin (BCG) is a live attenuated form of <i>Mycobacterium bovis</i> that was developed 100 years ago as a vaccine against tuberculosis (TB) and has been used ever since to vaccinate children globally. It has also been used as the first-line treatment in patients with n...

Full description

Bibliographic Details
Main Authors: Danielle Klinger, Brian L. Hill, Noam Barda, Eran Halperin, Ofer N. Gofrit, Charles L. Greenblatt, Nadav Rappoport, Michal Linial, Hervé Bercovier
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Vaccines
Subjects:
Bacillus Calmette–Guérin
tuberculosis
immunotherapy
non-muscle-invasive bladder cancer (NMIBC)
neurodegenerative disease
Online Access:https://www.mdpi.com/2076-393X/9/5/491

Similar Items

Similar Items